Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Methodology|Interests|Funding|Corrections
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Bibliographic record

Analytical and forensic aspects of counterfeit peptide hormones

Carvalho M, Dinis-Oliveira RJ. Drug Testing and Analysis 2023

Document identifier
CEI-BR-009
Series
Bibliographic record
Version
1.0
Published
30 Jul 2026
Last reviewed
30 Jul 2026
Certainty
Not rated

§1Bibliographic record

§1.1Record

Authors
Carvalho M, Dinis-Oliveira RJ
Title
Analytical and forensic aspects of counterfeit peptide hormones
Source
Drug Testing and Analysis
Year
2023
Volume, issue, pages
15(1):5–19
Digital object identifier
10.1002/dta.3379
PubMed identifier
not held by the Institute
Record type
Journal article
Institute identifier
CEI-BR-009

§1.2Institute documents citing this record

Table 1. Documents in the Institute set that cite this record.

DocumentSeries
Monograph: AOD-9604Compound monograph
Monograph: BPC-157Compound monograph
Monograph: Melanotan-IICompound monograph
Synthesis: Analytical surveys of unregulated peptide supplyEvidence synthesis
4 citing documents.

§1.3Subject tags

counterfeit forensic analytical

Compound Evidence Institute · CEI-BR-009 · https://compoundevidence.com/bibliography/carvalho2023/ · retrieved 30 July 2026
Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.